Search for Clinical Trial Results

Sponsored By

Angioedema - 88 Studies Found

Status Study
Completed Study Name: Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Date: 2009-12-18
Interventions: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin subcutaneous dose of 3
Completed Study Name: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Condition: Angioedema
Date: 2005-07-29
Interventions: Drug: C1 inhibitor concentrate (C1-esteraseremmer-N) every 5-7 days
Not yet recruiting Study Name: Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
Condition: Idiopathic Angioedema
Date: 2016-11-15
Interventions:
  • Drug: Omalizumab Omalizumab 30
Completed Study Name: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Date: 2007-02-07
Interventions: Drug: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study
Condition: Angioedema
Date: 2010-06-29
Interventions:
  • Drug: Icatibant (subcutaneous) and plazebo (intravenous)
Completed Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Date: 2007-02-21
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Date: 2007-04-17
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
Condition: Angioedema
Date: 2004-11-26
Interventions:
  • Drug: Icatibant 30 mg (3mL) su
Completed Study Name: Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
Condition: Hereditary Angioedema
Date: 2015-10-23
Interventions:
  • Drug: DX-2930 - 300mg/2wk 300

Active, not recruiting Study Name: Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
Condition: Hereditary Angioedema
Date: 2016-04-08
Interventions:
  • Drug: DX-2930 Rollover subject
Next >>>